Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
19.69
+0.40 (2.07%)
At close: Feb 27, 2026, 4:00 PM EST
19.74
+0.05 (0.25%)
After-hours: Feb 27, 2026, 7:00 PM EST
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $611.70 million as of February 27, 2026. Its market cap has increased by 620.01% in one year.
Market Cap
611.70M
Enterprise Value
499.28M
1-Year Change
620.01%
Ranking
Category
Stock Price
$19.69
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $611.70M, an increase of 15.70%. That is a compound annual growth rate of 7.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 611.70M | 10.62% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 634.98M |
| Zura Bio | 622.03M |
| MeiraGTx Holdings | 616.56M |
| Allogene Therapeutics | 613.51M |
| Ocugen | 613.15M |
| LB Pharmaceuticals | 613.00M |
| Design Therapeutics | 608.37M |
| Neumora Therapeutics | 603.28M |